Article3 Biotech2026
A repurposing screen of 29 media mixtures derived from 15 commercial serum-free media products identifies potential cost reductions for industrial animal cell cultivation.
Article in 3 Biotech, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We performed a repurposing screen of 15 commercial serum-free products, across 29 different media mix options, in Nunc™ EasYFlask™ cell culture flasks/CELLBIND® 6-well plates, agnostic of their recommended application or cell type. 20% v/v FBS DMEM was replaced with a given serum-free mix in a single step, and growth monitored over 6 days for the mouse muscle cell line, Sol8. 20 serum-free media mixes reduced or failed to increase growth, while 9 increased cell growth. 'Mix D', Fishers base medium containing 2% v/v Ultroser G serum alternative, showed the best combination of cell number increase and volumetric media cost reduction: 33% lower than 20% v/v FBS DMEM. Further Nunc™ EasYFlask™ cell culture flasks/CELLBIND® 6-well plates experiments showed that Mix D supported levels of Sol8 cell growth comparable to 20% v/v FBS DMEM, but with lower levels of metabolic activity. Comparable growth in Mix D was observed for Sol8 cells that had undergone a period of adaptation to the serum-free medium, and clonally-derived Sol8 sub-populations. Mix D also matched serum-containing media performance in supporting growth of the porcine muscle cell line, pMYOSC, the porcine pre-adipocyte fat cell line, pADSC and the mouse pre-adipocyte cell line, 3T3 L1 in Nunc™ EasYFlask™ cell culture flasks/CELLBIND® 6-well plates. 3T3 L1 cells cultivated in Mix D retained their capacity to differentiate into adipocytes, a cell type important for animal fat cultivation. The observation that Mix D supported growth of four different animal cell types at levels comparable to serum-containing medium recommends this formulation, and this repurposing screen approach, to researchers seeking serum alternatives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.